Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to evaluate the metabolism, the routes and extent of elimination, and drug levels of \[14C\]Navlimetostat (BMS-986504) in healthy female participants
Official title: A Phase 1 Study to Evaluate the Mass Balance, Metabolism, Excretion, and Pharmacokinetics of [14C]Navlimetostat (BMS-986504) at Steady State in Healthy Female Participants
Key Details
Gender
FEMALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
6
Start Date
2026-09-16
Completion Date
2026-12-05
Last Updated
2026-08-20
Healthy Volunteers
Yes
Conditions
Interventions
Navlimetostat
Specified dose on specified days
[14C]Navlimetostat
Specified dose on specified days
Locations (2)
Local Institution - 0001
Madison, Wisconsin, United States
Local Institution - 0002
Groningen, Provincie Groningen, Netherlands